Detalhe da pesquisa
1.
Structure-based design of low-nanomolar PIM kinase inhibitors.
Bioorg Med Chem Lett
; 25(3): 474-80, 2015 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25575657
2.
Enabling structure-based drug design of Tyk2 through co-crystallization with a stabilizing aminoindazole inhibitor.
BMC Struct Biol
; 12: 22, 2012 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22995073
3.
Design, synthesis, and biological evaluation of pyrazolopyrimidine-sulfonamides as potent multiple-mitotic kinase (MMK) inhibitors (part I).
Bioorg Med Chem Lett
; 21(18): 5633-7, 2011 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21798738
4.
ATP-Competitive MLKL Binders Have No Functional Impact on Necroptosis.
PLoS One
; 11(11): e0165983, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27832137
5.
Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases.
ACS Chem Biol
; 6(3): 234-44, 2011 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-21090814